Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.

Tailiang Lu Chenglong Li Cailing Xiang Yongqiang Gong Wei Peng Chaowu Chen

Published in: BioMed research international (2022)

These findings suggest that hypomethylation of the CISD1 promoter increases its expression in HCC. CISD1 is associated with prognosis and immune infiltrating levels of CD8+ T cells, macrophages, neutrophils, and DCs in HCC patients. These findings suggest that CISD1 can be used as a prognostic biomarker for determining prognosis in HCC.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
gene expression
transcription factor
poor prognosis
dna methylation
binding protein